Spanish plant-based protein producer Heura closes Series B financing
Spanish Food tech Start-up Heura Foods secures €40m in Series B financing round to expand product distribution.<br /><br /><br />
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1352 entries already.
Entries by Thomas Gabrielczyk
Spanish plant-based protein producer Heüra Foods closes Series B financing
/in News/by Thomas GabrielczykSpanish Food tech Start-up Heüra Foods secures €40m in Series B financing round to expand product distribution.<br /><br /><br />
Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN
/in News/by Thomas GabrielczykBiovian and 3P Biopharmaceuticals have created a new pan-European CDMO, dubbed 3PBIOVIAN. <h2></h2> <h2></h2>
£26m for Cystic Fibrosis Drug Trial
/in News/by Thomas GabrielczykEnterprise Therapeutics Ltd. has raised £26m for the Phase IIa trial of ETD001, a novel cystic fibrosis treatment, with investment led by Panakes Partners and participation from existing investors.
Alvotech Advances in Biosimilar Market with Successful AVT03 Study
/in News/by Thomas GabrielczykAVT03, a biosimilar candidate for osteoporosis treatment, showed promise in treating bone illnesses, according to results from a pharmacokinetic study by Alvotech SA.
Novozymes and Chr. Hansen Complete Merger, Forming Novonesis
/in News/by Thomas GabrielczykDanish Novozymes A/S and Chr. Hansen Holding A/S have completed their merger, creating a new company named Novonesis.
2:1 for new genomic techniques
/in News/by Thomas GabrielczykFollowing the AGRI Committee of the European Parliament, the lead ENVI Committee has also agreed to relax the rules for the authorisation of NGTs.
Deregulation of new genomic techniques before decision
/in News/by Thomas GabrielczykAfter the EU Parliament's Agriculture (AGRI) Committee called for a patent ban on NGT-1 breeds on 8 January, the ENVI Committee will give its input to the EU Commissions draft […]
Amsilk partners with 21st.BIO
/in News/by Thomas GabrielczykAMSilk GmbH and Danish 21st.BIO A/S announce partnership to accelerate the production of advanced materials made from spider silk-based proteins.
Onera Health raises US$32m in Series C round
/in News/by Thomas GabrielczykSleep diagnostics specialist Onera Health NV has closed a €30m (US$32m) Series C financing round co-led by EQT Life Sciences and Gimv.